How much is TORL BioTherapeutics worth in 2026?

TORL BioTherapeutics has a current valuation of N/A based on their Later Stage VC round and secondary market data.

How much funding has TORL BioTherapeutics raised?

TORL BioTherapeutics has raised $454.3M in total funding across 1 funding rounds.

TORL BioTherapeutics

Drug DiscoveryWebsite

TORL BioTherapeutics valuation and funding history | Last updated: October 7, 2025 | 1 funding rounds

Current Valuation

N/A

As of October 7, 2025

Total Funding Raised

$454.3M

Across 1 round

Last Round

Later Stage VC

$96.0M

Last Funding

Oct 2025

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
April 10, 2024	Later Stage VC (Series B2)	$158.3M	N/A	-

Valuation Analysis

Current Valuation Metrics

TORL BioTherapeutics is currently valued at N/A as of October 7, 2025. The company has raised a total of $454.3M in funding across 1 funding round.

Track TORL BioTherapeutics Valuation Updates

Get notified when TORL BioTherapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for TORL BioTherapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock TORL BioTherapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is TORL BioTherapeutics Worth in 2026?

TORL BioTherapeutics is a leading private company in the Drug Discovery sector. Track TORL BioTherapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How TORL BioTherapeutics Valuation is Determined

Private company valuations like TORL BioTherapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.